Lesson plan

GHP-88310

GHP-88310 (EIDD-3608) is an antiviral drug developed to target the measles morbillivirus, and also shows action against several related orthoparamyxoviruses. Prevalence of measles infection has grown in recent years due to declining vaccination rates, so development of effective antiviral drugs has become increasingly important. GHP-88310 is a broad-spectrum inhibitor of viral polymerases which are required for virus replication, and as well as measles itself, also shows efficacy against human parainfluenza virus type 3, Sendai virus and canine distemper virus in animal models.

Back to article

Article summary

GHP-88310 (EIDD-3608) is an antiviral drug developed to target the measles morbillivirus, and also shows action against several related orthoparamyxoviruses. Prevalence of measles infection has grown in recent years due to declining vaccination rates, so development of effective antiviral drugs has become increasingly important. GHP-88310 is a broad-spectrum inhibitor of viral polymerases which are required for virus replication, and as well as measles itself, also shows efficacy against human parainfluenza virus type 3, Sendai virus and canine distemper virus in animal models.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.